Although specific studies examining gastrointestinal physiology in CCM patients are lacking, increased intestinal permeability resulting from gut dysbiosis could elevate circulating LPS, activating endothelial TLR4 signaling and promoting CCM lesion development, as demonstrated in murine models. The gene discussed is TLR4; the disease is cerebral cavernous malformation.